Pharmafile Logo
Pharmafocus logo
Advanced Search
Sovaldi image

Sovaldi misses estimates but still makes history

October 29, 2014
Research and Development, Sales and Marketing FDA, Gilead, harvoni, hep C, sofosbuvir, sovaldi

The trajectory of Gilead’s new hep C pill Sovaldi has slowed but the drug is still on course to break …

News
sanofi_chris_viehbacher_2

Sanofi’s chief executive ousted

October 29, 2014
Medical Communications, Research and Development, Sales and Marketing Christopher Viehbacher, Sanofi

Sanofi’s chief executive Chris Viehbacher has been ejected from his role after the French firm’s board lost patience with his …

News
Google image

Google X developing diagnosis pill

October 29, 2014
Medical Communications, Research and Development, Sales and Marketing AbbVie, Pfizer, calico, diagnosis pill, google, google x, vida, wearables

Google is developing a new pill designed to send microscopic particles into the bloodstream in an effort to identify cancers, …

News
nhs_parliament_2_8

Cancer Drugs Fund ‘papering over the cracks of a bigger issue’

October 29, 2014
Medical Communications, Research and Development, Sales and Marketing Cancer, Kadcyla, NICE, breast cancer, reform

Breakthrough Breast Cancer has raised concerns to the government this week over the ever-increasing price of new oncology medicines. Over …

News
alison_doering

Quantum promotes senior head

October 29, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alison Doering, quantam pharmaceutical

Alison Doering has been promoted to head of group marketing and communications at medicines manufacturing firm Quantum Pharmaceutical.  Doering will …

Appointment

PrimeVigilance Limited upgrades its validated databases for pharmacovigilance and medical information – ARISg™ and agInquirer™.

October 28, 2014

PrimeVigilance Limited, a pharmaceutical service provider for Pharmacovigilance and Medical Information operations today announced the completion of a major upgrade …

News
Press release
Merck image

Merck revenue falls

October 28, 2014
Manufacturing and Production, Sales and Marketing Frazier, Merck, Q3, Victrelis, hep C, sovaldi

Merck has posted a set of disappointing financials for the latest quarter as it cuts cost across its business to …

News
peter_finan

Karus Therapeutics appoints two heads

October 28, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Peter Finan, Simon Roitt, karus

UK drug development firm Karus Therapeutics has grown its R&D team via two new appointments in Dr Simon Roitt, who …

Appointment
Celgene image

Celgene expands immunotherapy pipeline with Sutro

October 27, 2014
Research and Development, Sales and Marketing Celgene, PD-1 and PD-L1, Q3, oncology, sutro

Celgene has extended its collaboration with Sutro Biopharma and added a buyout option for the firm as the two companies …

News
AZ image

AZ oncology drug a ‘Phoenix from the flames’

October 27, 2014
Sales and Marketing AstraZeneca, CHMP, EC, lynparza, olaparib, oncology

As the possibility of a deal with Pfizer fades, AstraZeneca is continuing its argument for independence as a key cancer …

News

Scenesse recommended for rare sun disease in Europe

October 27, 2014
Sales and Marketing CHMP, Clinuvel Pharmaceuticals, EMA, EU, scenesse

The European Medicines Agency is recommending that Scenesse (afamelanotide) be approved for the prevention of severe sun burn in adults …

News

France Focus: Power without responsibility?

October 27, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing France, Lantus, Sanofi, Servier, hollande, perindopril, report

Population: 65.8 million (2013) Government: Unitary semi-presidential constitutional republic Leader: François Hollande of the centre-left Socialist Party Gross Domestic Product: …

Feature
perez

Cubist Pharmaceuticals names chief executive

October 27, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing cubist, perez

US biopharma firm Cubist Pharmaceuticals has named Robert Perez as its chief executive and who will begin the role from …

Appointment
prof_paul_workman

Cancer drug discovery system ‘broken’

October 24, 2014
Research and Development, Sales and Marketing Cancer, cancer research, oncology, paul workman

The global system for discovering new cancer drugs is ‘broken’ and failing to turn scientific advances into enough innovative new …

News
Lilly image

Lacklustre sales hit Lilly again

October 24, 2014
Sales and Marketing Q3, cymbalta, humilin, lilly, sales, zyprexa

Lilly is enduring one of the bleakest financial years in its history as patent expiries continue to take chunks out …

News
prof_tony_young

Innovation director appointed to NHS England

October 24, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, NHS England, tony young

NHS England has hired a new national clinical director for innovation in Professor Tony Young. Young’s role will be to …

Appointment

UK government and partners pay £230m for disease research

October 23, 2014
Research and Development, Sales and Marketing Arthritis Research UK, British Heart Foundation, Cancer Research UK, London, MRC, Osborne, UK, Wellcome Trust, dementia, research

A new partnership led by the Medical Research Council and the UK government will invest over £230 million in a …

News
Viiv image

GSK mulls $27 billion ViiV sell-off

October 23, 2014
Medical Communications, Sales and Marketing AIDS, Advair, GSK, HIV, Pfizer, Q3, Shionogi, Tivicay, ViiV

After a difficult few years and another poor quarter, GlaxoSmithKline has announced that it is looking to float its fast-growing …

News
yana_ignatova

J&J appoints head of marketing in northern Europe

October 23, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Johnson and Johnson, yana Ignatova

Johnson & Johnson has appointed Yana Ignatova to the position of head of marketing for its northern Europe division. Reporting …

Appointment
J&J image

J&J announces ‘major commitment’ to Ebola effort

October 22, 2014
Sales and Marketing Crucell, Ebola, J&J, JJ, Vaccine, bavarian, johnson, niaid

Johnson & Johnson will invest $200 million to accelerate and significantly expand the production of its Ebola vaccine programme. The …

News
The Gateway to Local Adoption Series

Latest content

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026

Rare diseases – spinal muscular atrophy

January 30, 2026

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026